| 36.91 Data as of May 17 |  +0.18 / +0.49%Today’s Change | 11.19 Today|||52-Week Range 40.27 | +130.69% Year-to-Date |
| Previous close | 36.73 |
| Today’s open | 36.72 |
| Day’s range | 36.11 - 38.14 |
| Volume | 662,736 |
| Average volume (3 months) | 148,354 |
| Market cap | $969.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -39.63% |
| Earnings growth (this year) | +6.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| USNAUSANA Health Science... | +1.30 | +2.03% |
| PBYIPuma Biotechnology I... | +2.58 | +7.42% |
| PDLIPDL BioPharma Inc | +0.04 | +0.49% |
| ACADACADIA Pharmaceutica... | +0.26 | +2.00% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$74.0M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Patrick J. Mahaffy |
Chief Financial Officer, Secretary & Executive VP Erle T. Mast |
Corporate headquarters Boulder, Colorado |
.
